| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Mr. Michael B. MoorePresident | -136.80k | 1.24M | 売り | 8.77 - 9.42 | 1.77M | -7.16% |
| 2026-03-18 | Mr. Michael B. MoorePresident | -136.80k | 1.24M | 売り | 8.77 - 9.42 | 1.77M | -7.16% |
| 2026-01-29 | Mr. Casey HoytCEO & Director | 39.80k | 0.00 | Derivative Exercise and Retained Stock | - | 2.34M | 1.73% |
| 2026-01-29 | Mr. Casey HoytCEO & Director | -13.27k | 99.22k | Derivative Exercise and Sale | 7.48 | 2.34M | - |
| 2026-01-29 | Mr. Casey HoytCEO & Director | -13.91k | 104.07k | Sale to Issuer | 7.48 | 2.34M | -0.59% |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | 26.84k | 0.00 | Derivative Exercise and Retained Stock | - | 390.31k | 7.38% |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | -8.95k | 66.93k | Derivative Exercise and Sale | 7.48 | 390.31k | - |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | -11.37k | 85.03k | Sale to Issuer | 7.48 | 390.31k | -2.83% |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | 9.79k | 0.00 | Derivative Exercise and Retained Stock | - | 105.64k | 10.22% |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | -3.27k | 24.42k | Derivative Exercise and Sale | 7.48 | 105.64k | - |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | -2.68k | 20.04k | Sale to Issuer | 7.48 | 105.64k | -2.47% |
| 2026-01-29 | Mr. Michael B. MoorePresident | 26.84k | 0.00 | Derivative Exercise and Retained Stock | - | 1.91M | 1.42% |
| 2026-01-29 | Mr. Michael B. MoorePresident | -8.95k | 66.92k | Derivative Exercise and Sale | 7.48 | 1.91M | - |
| 2026-01-29 | Mr. Michael B. MoorePresident | -7.34k | 54.92k | Sale to Issuer | 7.48 | 1.91M | -0.38% |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | 2.33k | 0.00 | Derivative Exercise and Retained Stock | - | 73.21k | 3.29% |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | -778.00 | 5.82k | Derivative Exercise and Sale | 7.48 | 73.21k | - |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | -802.00 | 6.00k | Sale to Issuer | 7.48 | 73.21k | -1.08% |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | 8.62k | 0.00 | Derivative Exercise and Retained Stock | - | 104.09k | 9.03% |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | -2.87k | 21.49k | Derivative Exercise and Sale | 7.48 | 104.09k | - |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | -2.36k | 17.62k | Sale to Issuer | 7.48 | 104.09k | -2.21% |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 10.77k | 0.00 | Derivative Exercise and Retained Stock | - | 46.49k | 30.16% |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -3.59k | 26.86k | Derivative Exercise and Sale | 7.48 | 46.49k | - |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -2.94k | 21.98k | Sale to Issuer | 7.48 | 46.49k | -5.95% |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | 117.55k | 0.00 | Derivative Exercise and Retained Stock | - | 374.84k | 45.69% |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | -8.55k | 64.07k | Derivative Exercise and Sale | 7.49 | 374.84k | - |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | -35.08k | 262.71k | Sale to Issuer | 7.49 | 374.84k | -8.56% |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | 13.32k | 0.00 | Derivative Exercise and Retained Stock | - | 98.52k | 15.63% |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | -3.33k | 24.93k | Derivative Exercise and Sale | 7.49 | 98.52k | - |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | -4.25k | 31.80k | Sale to Issuer | 7.49 | 98.52k | -4.13% |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | 11.72k | 0.00 | Derivative Exercise and Retained Stock | - | 97.82k | 13.61% |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | -2.93k | 21.95k | Derivative Exercise and Sale | 7.49 | 97.82k | - |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | -3.83k | 28.66k | Sale to Issuer | 7.49 | 97.82k | -3.76% |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | 3.40k | 0.00 | Derivative Exercise and Retained Stock | - | 71.68k | 4.98% |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | -850.00 | 6.37k | Derivative Exercise and Sale | 7.49 | 71.68k | - |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | -1.17k | 8.76k | Sale to Issuer | 7.49 | 71.68k | -1.60% |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 14.65k | 0.00 | Derivative Exercise and Retained Stock | - | 38.66k | 61.01% |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -3.66k | 27.43k | Derivative Exercise and Sale | 7.49 | 38.66k | - |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -4.78k | 35.82k | Sale to Issuer | 7.49 | 38.66k | -11.01% |
| 2026-01-21 | Mr. Michael B. MoorePresident | -9.36k | 70.09k | Sale to Issuer | 7.49 | 1.89M | -0.49% |
| 2026-01-21 | Mr. Michael B. MoorePresident | 34.21k | 0.00 | Derivative Exercise and Retained Stock | - | 1.89M | 1.84% |
| 2026-01-21 | Mr. Michael B. MoorePresident | -8.55k | 64.07k | Derivative Exercise and Sale | 7.49 | 1.89M | - |
| 2026-01-21 | Mr. Casey HoytCEO & Director | 49.60k | 0.00 | Derivative Exercise and Retained Stock | - | 2.31M | 2.19% |
| 2026-01-21 | Mr. Casey HoytCEO & Director | -12.40k | 92.88k | Derivative Exercise and Sale | 7.49 | 2.31M | - |
| 2026-01-21 | Mr. Casey HoytCEO & Director | -13.57k | 101.60k | Sale to Issuer | 7.49 | 2.31M | -0.58% |
| 2026-01-17 | Mr. Michael B. MoorePresident | 26.94k | 0.00 | Derivative Exercise and Retained Stock | - | 1.87M | 1.46% |
| 2026-01-17 | Mr. Michael B. MoorePresident | -6.74k | 49.37k | Derivative Exercise and Sale | 7.33 | 1.87M | - |
| 2026-01-17 | Mr. Michael B. MoorePresident | -8.55k | 62.66k | Sale to Issuer | 7.33 | 1.87M | -0.46% |
| 2026-01-17 | Mr. Casey HoytCEO & Director | 40.07k | 0.00 | Derivative Exercise and Retained Stock | - | 2.27M | 1.79% |
| 2026-01-17 | Mr. Casey HoytCEO & Director | -10.02k | 73.42k | Derivative Exercise and Sale | 7.33 | 2.27M | - |
| 2026-01-17 | Mr. Casey HoytCEO & Director | -12.12k | 88.82k | Sale to Issuer | 7.33 | 2.27M | -0.53% |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | 26.94k | 0.00 | Derivative Exercise and Retained Stock | - | 292.36k | 10.15% |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | -6.74k | 49.37k | Derivative Exercise and Sale | 7.33 | 292.36k | - |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | -8.55k | 62.67k | Sale to Issuer | 7.33 | 292.36k | -2.84% |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | 9.59k | 0.00 | Derivative Exercise and Retained Stock | - | 89.45k | 12.01% |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | -2.40k | 17.57k | Derivative Exercise and Sale | 7.33 | 89.45k | - |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | -3.13k | 22.96k | Sale to Issuer | 7.33 | 89.45k | -3.38% |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | 8.53k | 0.00 | Derivative Exercise and Retained Stock | - | 89.93k | 10.47% |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | -2.13k | 15.63k | Derivative Exercise and Sale | 7.33 | 89.93k | - |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | -2.78k | 20.41k | Sale to Issuer | 7.33 | 89.93k | -3.00% |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 4.88k | 0.00 | Derivative Exercise and Retained Stock | - | 28.79k | 20.43% |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1.22k | 8.95k | Derivative Exercise and Sale | 7.33 | 28.79k | - |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1.60k | 11.69k | Sale to Issuer | 7.33 | 28.79k | -5.25% |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 5.97k | 0.00 | Derivative Exercise and Retained Stock | - | 25.50k | 30.57% |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -2.99k | 21.83k | Derivative Exercise and Sale | 7.31 | 25.50k | - |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1.63k | 11.94k | Sale to Issuer | 7.31 | 25.50k | -6.02% |
| 2025-08-20 | Mr. Nitin KaushalIndependent Director | 15.73k | 0.00 | Derivative Exercise and Retained Stock | - | 142.58k | 12.40% |
| 2025-08-20 | Mr. Timothy SmokoffIndependent Director | 15.73k | 0.00 | Derivative Exercise and Retained Stock | - | 95.52k | 19.72% |
| 2025-08-20 | Mr. Randolph E. DobbsIndependent Chairman | 17.78k | 0.00 | Derivative Exercise and Retained Stock | - | 125.49k | 16.51% |
| 2025-08-20 | Ms. Sabrina HeltzIndependent Director | 15.73k | 0.00 | Derivative Exercise and Retained Stock | - | 67.49k | 30.39% |
| 2025-08-13 | Mr. Jerome Richard CambreVP of Sales | -4.88k | 35.74k | 売り | 7.32 - 7.33 | 84.19k | -5.48% |
| 2025-08-12 | Mr. Michael B. MoorePresident | -50.09k | 367.16k | 売り | 7.33 | 1.85M | -2.64% |
| 2025-01-29 | Mr. Michael B. MoorePresident | -8.95k | 74.09k | Sale to Issuer | 8.28 | 1.90M | -0.47% |
| 2025-06-27 | Mr. Michael B. MoorePresident | -181.32k | 809.51k | Derivative Exercise and Sale | 1.81 - 7.00 | 1.90M | - |
| 2025-06-30 | Mr. Nitin KaushalIndependent Director | -7.05k | 1.97k | Derivative Exercise and Sale | 6.63 - 6.91 | 126.84k | - |
| 2025-06-26 | Mr. Nitin KaushalIndependent Director | -42.95k | 16.23k | Derivative Exercise and Sale | 6.63 - 7.01 | 126.84k | - |
| 2025-06-26 | Mr. Nitin KaushalIndependent Director | -42.95k | 16.23k | Derivative Exercise and Sale | 6.63 - 7.01 | 126.84k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。